Collective Medical Technologies issued the following announcement on Nov. 12.
Collective Medical, delivering the nation’s largest and most effective network for care collaboration, today announced that California emergency department (ED) physicians now have access to California’s Controlled Substance Utilization Review and Evaluation System (CURES 2.0) prescription drug data through the Collective PlatformTM. The integration between CURES 2.0 and the Collective Platform simplifies physician workflow to ensure ED providers have essential opioid prescription history information about a patient in real-time at the point of care.
The Collective NetworkTM has been proven to help care teams combat the opioid epidemic across the nation. In addition to similar PDMP integrations in numerous states, Collective arms ED providers with holistic information about patients through its platform’s Insights™ functionality, including information on possible social determinants, safety and security alerts, utilization patterns across all points of care and care team contact information. Integration with CURES 2.0 will simplify and enrich the ED provider experience in California, supporting them in making the most appropriate care decisions, and amplifying the impact of the CURES 2.0 database for patients across the state.
California Assembly Bill 40 (AB 40) was passed into law in October 2017, allowing healthcare practitioners and pharmacists to submit a query to the CURES database through a health information technology system, such as the Collective Platform. Following passage of AB 40, the California Department of Justice CURES 2.0 Program implemented new technical innovations to enable authorized healthcare practitioners and pharmacists at hospitals across the state of California to connect to the CURES 2.0 database.
With a more holistic view of the patient, provided both through the Collective Platform’s Insights functionality and CURES 2.0, care teams have an opportunity to do more than simply avoid writing a prescription for narcotics. Armed with more comprehensive information, providers can consider novel treatment models, such as ED Bridge, which supports EDs throughout California to develop and implement plans for 24/7 access to buprenorphine for patients with opioid use disorder as a ‘bridge’ into outpatient medication-assisted treatment. A recent article by the New York Times covering ED Bridge mentioned a study out of Yale-New Haven Hospital finding that addicted patients given buprenorphine in the ED where twice as likely to be in treatment a month later as those who were provided with typical patient education materials.
The Collective Network is live in states across the country including Washington, California, Oregon, Massachusetts, Virginia, West Virginia, Alaska, New Mexico and many others. Collective’s real-time, risk-adjusted event notification and care collaboration platform serves all points of care, including emergency department, inpatient, post-acute, mental and behavioral, and ambulatory settings, as well as ACOs and health plans.
“We have an obligation to support ED care teams in making the best care decisions possible,” says Chris Klomp, CEO of Collective Medical. “By integrating our platform with CURES, we’re taking one more step toward giving ED providers the insights they need to catch vulnerable patients before they fall, both in California and nationwide.”
Collective is endorsed as a best practice for emergency medicine by the American College of Emergency Physicians and has been recognized by Inc. Magazine and by the MountainWest Capital Network as one of Utah’s fastest growing companies.
Learn more about Collective’s impact at www.collectivemedical.com.
Original source can be found here.